PDS Biotechnology (PDSB) said Thursday it is selling about 7.3 million common shares and warrants to purchase up to about 7.3 million common shares in a registered direct offering at a combined purchase price of $1.50 for institutional investors and $1.66 for certain PDS Biotechnology directors.
The company said about $11 million will be fully funded upon the closing of the offering, which is expected to occur on or about Friday, and up to $11 million more may be funded upon full cash exercise of the warrants, which have an exercise price of $1.50 per share, according to the company.
Net proceeds from the offering are expected to be used for research and development expenses and general corporate purposes, the company said.
Shares of PDS Biotechnology were up 4.6% in recent Thursday trading.
Price: 1.61, Change: +0.07, Percent Change: +4.55
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.